comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 01:53:53 - browse：252

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout LOUD podcast: Merger Mondays, Ozempic panic

WSS

Reconstructing family trees of blood cells may help predict disease

There’s no way to know how good AI health technologies are

How clinical AI models' predictive power can degrade over time

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Wegovy leads to weight loss. Can it treat depression, too?

Peter Marks talks Operation Warp Speed for Rare Diseases

focus

comprehensive

focus

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Merger Mondays, Ozempic panic

BioMarin wins approval for gene therapy to treat hemophilia A

Life sciences deals on track to hit lowest point since 2017

Sports medicine is finally prioritizing gender equality

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Investment in vaccine development is lagging, report finds

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wegovy leads to weight loss. Can it treat depression, too?

hotspot

Why you shouldn’t ask, “What country has the best health care?”

Medicare to cover more brain scans related to Alzheimer’s drugs

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Bernie Sanders bashes nonprofit hospitals over their tax breaks

There’s no way to know how good AI health technologies are

Vertex non

hotspot

entertainment

focus

knowledge